Plasma Lipid Profiling Identifies Phosphatidylcholine 34:3 and Triglyceride 52:3 as Potential Markers Associated with Disease Severity and Oxidative Status in Chronic Obstructive Pulmonary Disease

[1]  I. Garcia-Arcos,et al.  Alveolar lipids in pulmonary disease. A review , 2020, Lipids in Health and Disease.

[2]  M. Campos,et al.  Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD) , 2020, PloS one.

[3]  Y. Moodley,et al.  Metabolomics in chronic lung diseases , 2020, Respirology.

[4]  Yali Lv,et al.  Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis , 2018, Lipids in Health and Disease.

[5]  Manuel C. Peitsch,et al.  Alterations in Serum Polyunsaturated Fatty Acids and Eicosanoids in Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) , 2016, International journal of molecular sciences.

[6]  Z. Tabka,et al.  Alteration in systemic markers of oxidative and antioxidative status in Tunisian patients with asthma: relationships with clinical severity and airflow limitation , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.

[7]  A. Postle,et al.  Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila , 2015, Cell.

[8]  M. A. Lasunción,et al.  Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry. , 2015, Chemistry and physics of lipids.

[9]  W. Bernhard,et al.  Plasma Phosphatidylcholine Alterations in Cystic Fibrosis Patients: Impaired Metabolism and Correlation with Lung Function and Inflammation , 2015, Cellular Physiology and Biochemistry.

[10]  V. Nachiappan,et al.  In vitro exposure of tobacco specific nitrosamines decreases the rat lung phospholipids by enhanced phospholipase A2 activity. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  T. Spector,et al.  Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study , 2014, Circulation.

[12]  M. Setou,et al.  Cilostazol inhibits accumulation of triglycerides in a rat model of carotid artery ligation. , 2013, Journal of vascular surgery.

[13]  J. Shaw,et al.  Plasma lipid profiling in a large population-based cohort[S] , 2013, Journal of Lipid Research.

[14]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[15]  A. Moser,et al.  Functions of plasmalogen lipids in health and disease. , 2012, Biochimica et biophysica acta.

[16]  Claudio R. Santos,et al.  Lipid metabolism in cancer , 2012, The FEBS journal.

[17]  G. Schmitz,et al.  Plasmalogens the neglected regulatory and scavenging lipid species. , 2011, Chemistry and physics of lipids.

[18]  J. Jais,et al.  A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients , 2009, PloS one.

[19]  M. Triggiani,et al.  Secreted phospholipases A(2): A proinflammatory connection between macrophages and mast cells in the human lung. , 2009, Immunobiology.

[20]  Christian Gieger,et al.  Metabolic Profiling Reveals Distinct Variations Linked to Nicotine Consumption in Humans — First Results from the KORA Study , 2008, PloS one.

[21]  S. P. Nana-Sinkam,et al.  Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. , 2007, American journal of respiratory and critical care medicine.

[22]  I. Rahman,et al.  Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. , 2006, Pharmacology & therapeutics.

[23]  H. Wu,et al.  Surfactant lipid peroxidation damages surfactant protein A and inhibits interactions with phospholipid vesicles Published, JLR Papers in Press, March 16, 2004. DOI 10.1194/jlr.M300360-JLR200 , 2004, Journal of Lipid Research.

[24]  R. Zoeller,et al.  Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.

[25]  J. Torday,et al.  Biologic Role of Fetal Lung Fibroblast Triglycerides as Antioxidants , 2001, Pediatric Research.

[26]  M. Rüdiger,et al.  Preterm infants with high polyunsaturated fatty acid and plasmalogen content in tracheal aspirates develop bronchopulmonary dysplasia less often , 2000, Critical care medicine.

[27]  B. Engelmann,et al.  Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol. , 1999, Free radical biology & medicine.

[28]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[29]  M. Grendár,et al.  Plasma based targeted metabolomic analysis reveals alterations of phosphatidylcholines and oxidative stress markers in guinea pig model of allergic asthma. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[30]  H. Haagsman,et al.  Toxic oxidant species and their impact on the pulmonary surfactant system , 2009, Lung.

[31]  M. Creer,et al.  Phospholipase A2-catalyzed hydrolysis of plasmalogen phospholipids in thrombin-stimulated human platelets. , 2007, Thrombosis research.

[32]  P. Barnes,et al.  Alveolar macrophages in chronic obstructive pulmonary disease (COPD). , 2004, Cellular and molecular biology.